Federal Scrutiny of Gender-Affirming Care for Minors Intensifies
Table of Contents
A Department of Justice (DOJ) citation revealed this week indicates the Trump governance is demanding confidential information from hospitals and doctors providing gender-affirming care to minors. This action is part of a broader effort to increase oversight and perhaps restrict access to these treatments.
Demands for Extensive Patient and Hospital Data
The citation, sent in June to Children’s Hospital of Philadelphia, includes a seven-page list requesting thorough data. This includes all written records and registrations of doctors providing gender-affirming care – encompassing therapies, puberty blockers, hormones, and surgeries.Critically,the request extends to sensitive patient data such as birth dates,addresses,and social security numbers.
According to a report by The Washington Post, the citation to the Philadelphia hospital isn’t limited to medical and financial records. It also demands access to emails, text messages, Zoom recordings, and even communications from encrypted applications like WhatsApp.
Sources speaking anonymously to The Washington Post revealed that hospitals targeted are located in both states with restrictive laws regarding gender-affirming care and those where such treatments remain legal.
Broader Government Actions and Impact on Healthcare Providers
This citation is part of a larger strategy, as reported by The New York Times. As May, the Centers for Medicare & Medicaid Services (CMS) has sent letters to nine prominent children’s hospitals requesting information on gender treatments for minors, warning that federal funding is contingent upon adherence to “rigorous” standards.
Concurrently, in June, the FBI requested the public to report instances of adolescent transition surgery, and the DOJ initiated investigations into pharmaceutical manufacturers producing drugs used in these therapies.
These actions have already led over a dozen hospitals to reduce or close thier clinics offering care to transgender adolescents, even in states with Democratic leadership.
Climate of Fear Among Doctors
Doctors cited by The Washington Post describe a growing climate of fear. Some have been required to turn over work phones to superiors or are constantly concerned about surveillance, fearing potential criminal charges for providing legal treatments within their jurisdictions.
Prevalence of gender-Affirming Care
Research published in JAMA Pediatrics indicates that less than 0.1% of adolescents in the United States access puberty blockers or hormonal therapies. This data challenges claims of widespread or inappropriate use of these treatments.
Potential for Expanded Restrictions
Legal experts caution that this ruling could pave the way for other states to prohibit gender-affirming care for transgender adults. leah Litman, a constitutional law professor at the University of Michigan, told The Advocate that the conservative majority on the Supreme Court is establishing a foundation for implementing even broader restrictions.
Key Takeaways
- The DOJ is requesting extensive data on gender-affirming care for minors from hospitals nationwide.
- Federal agencies are increasing scrutiny of treatments and pharmaceutical manufacturers.
- Hospitals are responding by reducing or closing clinics offering this care.
- Doctors are expressing fear of legal repercussions.
- The prevalence of gender-affirming care among adolescents is very low.
Publication Date: 2025/08/21 22:54:37